2019
DOI: 10.1186/s12884-019-2357-9
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review on the utility of non-invasive electrophysiological assessment in evaluating for intra uterine growth restriction

Abstract: Background Non-invasive electrophysiological assessment (NIEA) is an evolving area in fetal surveillance and is attracting increasing research interest. There is however, limited data outlining its utility in evaluating intra uterine growth restriction (IUGR). The objective of this study was to carry out a systematic review to outline the utility of NIEA parameters in evaluating IUGR. Methods A systematic review of peer reviewed literature was performed, searching PUBME… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 62 publications
0
2
0
Order By: Relevance
“…The Monica AN24 monitor (Monica Healthcare, Nottingham, UK) and the Meridian M100/M1000 monitors (MindChild Medical, North Andover, MA), both which have been approved by the Food and Drug Administration (FDA) and the European Commission (CE), are two commercial devices commonly used for non-invasive fECG ( Behar et al 2016 ). However, although the cost of fECG devices is relatively low ($4500 for the Monica Novii Wireless Patch System ( Cardo Medical 2020 )), non-invasive fECG is still not widely used since the systems still require further testing to definitively demonstrate that the morphological analysis is similar to that provided by the scalp electrocardiography method ( Smith et al 2019 , Kahankova et al 2019 ).…”
Section: Comparison Of Fetal Cardiac Monitoring Methodsmentioning
confidence: 99%
“…The Monica AN24 monitor (Monica Healthcare, Nottingham, UK) and the Meridian M100/M1000 monitors (MindChild Medical, North Andover, MA), both which have been approved by the Food and Drug Administration (FDA) and the European Commission (CE), are two commercial devices commonly used for non-invasive fECG ( Behar et al 2016 ). However, although the cost of fECG devices is relatively low ($4500 for the Monica Novii Wireless Patch System ( Cardo Medical 2020 )), non-invasive fECG is still not widely used since the systems still require further testing to definitively demonstrate that the morphological analysis is similar to that provided by the scalp electrocardiography method ( Smith et al 2019 , Kahankova et al 2019 ).…”
Section: Comparison Of Fetal Cardiac Monitoring Methodsmentioning
confidence: 99%
“…The values of phase rectified signal averaging are known to capture fetal neurological development. The fetal growth restriction (FGR) was found to be featured by decreased variables of acceleration capacity and deceleration capacity (AC/DC) [4][5][6]. FGR is known to be associated with an increased rate of fetal deterioration.…”
Section: Introductionmentioning
confidence: 99%